Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: BKM120 + lapatinib
Sponsor: Institut Paoli-Calmettes